Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00790127 |
|
Recruitment Status :
Completed
First Posted : November 13, 2008
Last Update Posted : May 20, 2011
|
Sponsor:
HemaQuest Pharmaceuticals Inc.
Information provided by:
HemaQuest Pharmaceuticals Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 2010 |
| Actual Study Completion Date : | May 2010 |
| Certification/Extension First Submitted : | May 13, 2011 |